bluebird bio Inc (BLUE)
0.348
+0.05
(+16.82%)
USD |
NASDAQ |
Nov 22, 16:00
0.34
-0.01
(-2.30%)
After-Hours: 20:00
bluebird bio Gross Profit Margin (Quarterly): -11.02% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -11.02% |
| June 30, 2024 | -79.78% |
| March 31, 2024 | -39.26% |
| December 31, 2023 | -55.63% |
| September 30, 2023 | 26.36% |
| June 30, 2023 | 2.80% |
| March 31, 2023 | -131.5% |
| December 31, 2022 | 66.67% |
| September 30, 2022 | |
| June 30, 2022 | -14.88% |
| March 31, 2022 | -327.2% |
| December 31, 2021 | -129.2% |
| September 30, 2021 | -1.80K% |
| June 30, 2021 | -10.54K% |
| March 31, 2021 | 35.57% |
| Date | Value |
|---|---|
| December 31, 2020 | 98.38% |
| September 30, 2020 | 93.16% |
| June 30, 2020 | 99.22% |
| March 31, 2020 | 95.31% |
| December 31, 2019 | 94.51% |
| September 30, 2019 | 90.33% |
| June 30, 2019 | 95.39% |
| March 31, 2019 | 96.55% |
| December 31, 2018 | 95.75% |
| September 30, 2018 | 99.75% |
| June 30, 2018 | 99.73% |
| March 31, 2018 | 99.89% |
| December 31, 2017 | 99.83% |
| September 30, 2017 | 85.73% |
| June 30, 2017 | 97.49% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-10.54K%
Minimum
Jun 2021
99.22%
Maximum
Jun 2020
-658.9%
Average
-11.02%
Median
Sep 2024
Gross Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 77.14% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 53.37% |
| Electromed Inc | 78.34% |
| Armata Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -245.9% |
| Return on Assets | -50.94% |
| Return on Invested Capital | -181.9% |
| Profit Margin (Quarterly) | -573.0% |
| Operating Margin (Quarterly) | -604.1% |
| Return on Net Operating Assets | -83.21% |